Velan Capital Investment Management as of June 30, 2025
Portfolio Holdings for Velan Capital Investment Management
Velan Capital Investment Management holds 50 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Heron Therapeutics (HRTX) | 14.3 | $15M | 7.0M | 2.07 | |
| Veronapharma Sponsoredads (VRNA) | 8.9 | $9.0M | 95k | 94.58 | |
| Jaspertherapeutics Comnew (JSPR) | 7.9 | $8.0M | 1.4M | 5.55 | |
| Protaratherapeutics Comstk (TARA) | 6.4 | $6.5M | 2.1M | 3.03 | |
| Zevratherapeutics Comnew (ZVRA) | 6.2 | $6.3M | 715k | 8.81 | |
| Tourmaline Bio (TRML) | 6.2 | $6.3M | 394k | 15.99 | |
| Praxisprecisionmedicinesi Comnew (PRAX) | 6.2 | $6.3M | 149k | 42.05 | |
| Cidaratherapeutics Comnew (CDTX) | 4.8 | $4.9M | 100k | 48.71 | |
| Alumis (ALMS) | 4.8 | $4.9M | 1.6M | 3.00 | |
| Arvinas Ord (ARVN) | 3.6 | $3.7M | 500k | 7.36 | |
| Scpharmaceuticals (SCPH) | 3.5 | $3.5M | 918k | 3.81 | |
| Rezolute Comnew (RZLT) | 3.3 | $3.3M | 750k | 4.46 | |
| Liquidiacorporation Comnew (LQDA) | 2.9 | $3.0M | 239k | 12.46 | |
| Mineralys Therapeutics (MLYS) | 2.3 | $2.4M | 175k | 13.53 | |
| Sutro Biopharma (STRO) | 2.2 | $2.2M | 3.1M | 0.71 | |
| Inspiremd (NSPR) | 2.0 | $2.1M | 904k | 2.27 | |
| Perspectivetherapeutics Comnew (CATX) | 1.7 | $1.7M | 500k | 3.44 | |
| Replimune Group (REPL) | 1.7 | $1.7M | 183k | 9.29 | |
| Tela Bio (TELA) | 1.4 | $1.4M | 747k | 1.94 | |
| Edesabiotech Comnew (EDSA) | 1.4 | $1.4M | 688k | 2.03 | |
| Nektartherapeutics Call Call Option | 1.3 | $1.3M | 50k | 25.84 | |
| Miragen Therapeutics (VRDN) | 1.2 | $1.2M | 87k | 13.98 | |
| Upstream Bio (UPB) | 1.2 | $1.2M | 107k | 10.98 | |
| Eledon Pharmaceuticals (ELDN) | 0.9 | $919k | 339k | 2.71 | |
| Avalotherapeutics Comnew (AVTX) | 0.8 | $773k | 155k | 4.99 | |
| Tenaxtherapeutics Comnew (TENX) | 0.5 | $480k | 83k | 5.76 | |
| Corbuspharmaceuticalshldgs Comnew (CRBP) | 0.4 | $407k | 59k | 6.90 | |
| Kiora Pharmaceuticals (KPRX) | 0.3 | $352k | 122k | 2.88 | |
| Protagonist Therapeutics (PTGX) | 0.2 | $205k | 3.7k | 55.27 | |
| Cytomx Therapeutics (CTMX) | 0.2 | $170k | 75k | 2.27 | |
| Nurix Therapeutics (NRIX) | 0.1 | $114k | 10k | 11.39 | |
| Geron Corporation (GERN) | 0.1 | $99k | 70k | 1.41 | |
| Wavelifesciences SHS (WVE) | 0.1 | $98k | 15k | 6.50 | |
| Larimar Therapeutics (LRMR) | 0.1 | $95k | 33k | 2.89 | |
| Gossamer Bio (GOSS) | 0.1 | $92k | 75k | 1.23 | |
| Proqrthrapeuticsnv Shseuro (PRQR) | 0.1 | $92k | 45k | 2.04 | |
| Ventyx Biosciences (VTYX) | 0.1 | $86k | 40k | 2.14 | |
| Erasca (ERAS) | 0.1 | $83k | 65k | 1.27 | |
| Alector (ALEC) | 0.1 | $77k | 55k | 1.40 | |
| Terns Pharmaceuticals (TERN) | 0.1 | $75k | 20k | 3.73 | |
| Design Therapeutics (DSGN) | 0.1 | $67k | 20k | 3.37 | |
| Context Therapeutics (CNTX) | 0.1 | $66k | 100k | 0.66 | |
| Ovid Therapeutics (OVID) | 0.1 | $53k | 160k | 0.33 | |
| Immix Biopharma (IMMX) | 0.1 | $52k | 25k | 2.07 | |
| Vyne Therapeutics (VYNE) | 0.0 | $50k | 30k | 1.65 | |
| Aclaris Therapeutics (ACRS) | 0.0 | $46k | 33k | 1.42 | |
| 4d Molecular Therapeutics In (FDMT) | 0.0 | $45k | 12k | 3.71 | |
| Pyxisoncology Commonstock (PYXS) | 0.0 | $44k | 40k | 1.10 | |
| Pmv Pharmaceuticals (PMVP) | 0.0 | $37k | 35k | 1.06 | |
| Nextcure (NXTC) | 0.0 | $21k | 45k | 0.46 |